Latest Funding Risk News

Carawine Resources reports a critical quarter marked by a looming Federal Court hearing on a compulsory acquisition by major shareholder QGold, alongside a $1.7 million loan facility that underpins ongoing operations amid deferred exploration programs.

Jindalee Lithium’s McDermitt Lithium Project has been designated a FAST-41 Transparency Project, enhancing federal permitting visibility and coordination to accelerate development in the US critical minerals sector.

Maximus Resources Limited has issued a Target's Statement recommending shareholders accept Astral Resources NL's off-market takeover bid, which offers a significant premium and improved liquidity. The offer, valuing Maximus shares at approximately $0.073 each, aims to consolidate gold assets in Western Australia under Astral's larger portfolio.

Sarama Resources has completed the second tranche of its A$2 million equity placement, issuing options to institutional investors after shareholder approval. The funds are earmarked for advancing exploration and supporting working capital.

Micro-X Ltd has announced a $6 million capital raising alongside a $2.4 million strategic investment from Billion Prima, underpinning its pivot towards medical imaging and cashflow stability.

Rapid Lithium Limited has closed its partially underwritten entitlement offer, raising $53,860 with 37 applications, and is now working to place the remaining shortfall by April 2025.

Bridge SaaS Limited has recorded its first cashflow positive quarter, driven by strong growth at Brightside and strategic moves into the NDIS and DES sectors. The company is advancing plans for a tailored NDIS 'lite' SaaS offering aimed at smaller providers.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Allup Limited reports a challenging quarter with significant cash outflows from operations and investing, relying heavily on financing activities. The company is pursuing a $1.3 million entitlement issue to support ongoing feasibility work.

Image Resources NL has made significant strides in advancing its Atlas Project, overcoming bushfire disruptions and securing a US$20 million prepayment facility to fully fund operations through to first revenue, with commissioning and initial production on track for early 2025.

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

Omega Oil and Gas Limited has successfully raised A$7 million in a strongly supported institutional placement, positioning the company to advance its Canyon-1H fracture stimulation and appraisal program.